Wed, July 13, 2022
Tue, July 12, 2022
Mon, July 11, 2022
Sun, July 10, 2022
Fri, July 8, 2022
Thu, July 7, 2022

Robert Burns Maintained (BNTX) at Strong Buy with Decreased Target to $283 on, Jul 11th, 2022


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-decreased-target-to-283-on-jul-11th-2022.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Strong Buy with Decreased Target from $298 to $283 on, Jul 11th, 2022.

Robert has made no other calls on BNTX in the last 4 months.



There are 5 other peers that have a rating on BNTX. Out of the 5 peers that are also analyzing BNTX, 3 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold and Held Target at $180 on, Wednesday, June 1st, 2022
  • Chris Shibutani of "Goldman Sachs" Maintained at Hold with Decreased Target to $206 on, Tuesday, May 24th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $195 on, Tuesday, May 10th, 2022


These are the ratings of the 2 analyists that currently disagree with Robert


  • William Maughan of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $192 on, Wednesday, July 6th, 2022
  • Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $300 on, Tuesday, April 5th, 2022

Publication Contributing Sources